deltatrials
Unknown PHASE2 INTERVENTIONAL 3-arm NCT03260920

Intranasal Oxytocin for Frontotemporal Dementia (FOXY)

A Phase 2 Clinical Trial of Intranasal Oxytocin for Frontotemporal Dementia

Sponsor: Berry Consultants

Conditions Frontotemporal Dementia
Interventions Syntocinon
Updated 20 times since 2017 Last updated: Dec 7, 2023 Started: Jan 31, 2018 Primary completion: Jun 30, 2023 Completion: Dec 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Frontotemporal Dementia, this trial is ongoing. The trial is conducted by Berry Consultants and has accumulated 20 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2017 – ~Dec 2017 · 3 months · monthly snapshot~Dec 2017 – ~Mar 2018 · 3 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Dec 2018 · 5 months · monthly snapshot~Dec 2018 – ~Feb 2019 · 2 months · monthly snapshot~Feb 2019 – ~Mar 2020 · 13 months · monthly snapshot~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Feb 2023 · 17 months · monthly snapshot~Feb 2023 – ~Apr 2023 · 59 days · monthly snapshot~Apr 2023 – ~Nov 2023 · 7 months · monthly snapshot~Nov 2023 – ~Jan 2024 · 2 months · monthly snapshot~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshot~Jan 2025 – ~Apr 2025 · 3 months · monthly snapshot~Apr 2025 – ~Sep 2025 · 5 months · monthly snapshot~Sep 2025 – ~Jan 2026 · 4 months · monthly snapshot~Jan 2026 – present · 6 months · monthly snapshot

Change History

20 versions recorded

  1. Jan 2026 — Present [monthly]

    Unknown PHASE2

    Status: Active Not Recruiting → Unknown

  2. Sep 2025 — Jan 2026 [monthly]

    Active Not Recruiting PHASE2

  3. Apr 2025 — Sep 2025 [monthly]

    Active Not Recruiting PHASE2

  4. Jan 2025 — Apr 2025 [monthly]

    Active Not Recruiting PHASE2

  5. Sep 2024 — Jan 2025 [monthly]

    Active Not Recruiting PHASE2

▶ Show 15 earlier versions

  1. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  2. Jan 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

  3. Nov 2023 — Jan 2024 [monthly]

    Active Not Recruiting PHASE2

  4. Apr 2023 — Nov 2023 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  5. Feb 2023 — Apr 2023 [monthly]

    Recruiting PHASE2

  6. Sep 2021 — Feb 2023 [monthly]

    Recruiting PHASE2

  7. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE2

  8. Mar 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  9. Feb 2019 — Mar 2020 [monthly]

    Recruiting PHASE2

  10. Dec 2018 — Feb 2019 [monthly]

    Recruiting PHASE2

  11. Jul 2018 — Dec 2018 [monthly]

    Recruiting PHASE2

  12. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE2

  13. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  14. Dec 2017 — Mar 2018 [monthly]

    Not Yet Recruiting PHASE2

  15. Sep 2017 — Dec 2017 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Berry Consultants
  • Canadian Institutes of Health Research (CIHR)
  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
  • Weston Brain Institute
Data source: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations